Glucocorticosteroids Effects on Brain Development in the Preterm Infant: A Role for Microglia?

Area of Science:

• Neonatal Medicine
• Neuroscience
• Immunology

Background:

• Prematurity affects 15 million newborns annually, causing significant neonatal mortality and long-term morbidity.
• Preterm infants face risks including respiratory issues, sepsis, and neurodevelopmental disorders.
• Perinatal glucocorticosteroids are used to manage prematurity complications, but may impact brain development.

Purpose of the Study:

• To review the effects of endogenous and exogenous glucocorticosteroids on brain development in preterm infants.
• To explore the potential role of microglia in mediating these glucocorticosteroid effects.
• To understand the impact on neurodevelopmental outcomes in premature infants.

Main Methods:

• Literature review of clinical trials and studies on glucocorticosteroid exposure in preterm infants.
• Analysis of research on neuroinflammation and the role of microglia in brain development.
• Synthesis of findings on the relationship between glucocorticosteroids, microglia, and preterm brain injury.

Main Results:

• Glucocorticosteroids show short-term benefits for preterm infants but are linked to abnormal brain development in some studies.
• Neuroinflammation is a key factor in preterm infant brain injury, with microglia playing a significant role.
• Microglia are involved in modulating brain development and may be a target for glucocorticosteroid actions.

Conclusions:

• Glucocorticosteroids have a complex impact on preterm infant brain development, with potential adverse effects.
• Microglia are emerging as critical mediators in glucocorticosteroid-induced changes in the developing preterm brain.
• Further research is needed to elucidate the mechanisms and optimize the use of glucocorticosteroids to mitigate neurodevelopmental risks.